Scholarlink

<p>Mutations in the <i>MYH9</i> gene, which encodes the heavy chain of the actin-based molecular motor non-muscle myosin II-A (NM2-A), cause a spectrum of rare blood disorders collectively termed <i>MYH9</i>-related diseases (<i>MYH9</i>-RD). Previous data indicate that mutations in the motor domain result in more severe phenotypes than those in the dimerization/filamentation domain. Here, we show that N93K mutation, previously described as motor-impairing, has only a minor effect on myosin motor function in vitro, but it significantly enhances NM2-A filament stability and interaction with the chaperone UNC45a. When expressed in stress fiber-competent cells, e.g., COS7 or U2OS, and stress fiber-incompetent cells, e.g., MEG-01, NM2-A N93K formed amorphous aggregates that colocalized with wild-type NM2-A, NM2-B and UNC45a, but not F-actin, tropomyosin-4 or phosphoSer19, active, RLC. Another motor mutant, NM2-A R705H, caused milder defects in filament stability, adhesion maturation and aggregation in both types of cells. Conversely, the tail domain mutant NM2-A E1841K enhanced filament stability in COS7 cells without forming aggregates, while it promoted the formation of small, elongated aggregates in MEG-01 cells that did not co-localize with wild type NM2-A. These data indicate that the molecular defect caused by NM2A-N93K affects the distribution and function of the wild type allele, whereas NM2-A E1841K aggregates do not affect the wild type allele, which could constitute the molecular basis of the differences in severity in mutant <i>MYH9</i> allele carriers. </p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

MYH9 mutations differentially stabilize non-muscle myosin II filaments and induce distinct cellular aggregation phenotypes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月28日

查看全文
  • Clara Llorente-González,
  • Kamila Mustafina,
  • Gloria Asensio-Juárez,
  • Marina Garrido-Casado,
  • Vanessa C. Talayero,
  • Rafael Pérez-Díaz,
  • Hugo Ramos-Solano,
  • James R. Sellers,
  • Krishna Chinthalapudi,
  • Paul W. Wiseman,
  • Sarah M. Heissler,
  • Miguel Vicente-Manzanares

摘要

Mutations in the MYH9 gene, which encodes the heavy chain of the actin-based molecular motor non-muscle myosin II-A (NM2-A), cause a spectrum of rare blood disorders collectively termed MYH9-related diseases (MYH9-RD). Previous data indicate that mutations in the motor domain result in more severe phenotypes than those in the dimerization/filamentation domain. Here, we show that N93K mutation, previously described as motor-impairing, has only a minor effect on myosin motor function in vitro, but it significantly enhances NM2-A filament stability and interaction with the chaperone UNC45a. When expressed in stress fiber-competent cells, e.g., COS7 or U2OS, and stress fiber-incompetent cells, e.g., MEG-01, NM2-A N93K formed amorphous aggregates that colocalized with wild-type NM2-A, NM2-B and UNC45a, but not F-actin, tropomyosin-4 or phosphoSer19, active, RLC. Another motor mutant, NM2-A R705H, caused milder defects in filament stability, adhesion maturation and aggregation in both types of cells. Conversely, the tail domain mutant NM2-A E1841K enhanced filament stability in COS7 cells without forming aggregates, while it promoted the formation of small, elongated aggregates in MEG-01 cells that did not co-localize with wild type NM2-A. These data indicate that the molecular defect caused by NM2A-N93K affects the distribution and function of the wild type allele, whereas NM2-A E1841K aggregates do not affect the wild type allele, which could constitute the molecular basis of the differences in severity in mutant MYH9 allele carriers.